Patents by Inventor Brigitte Dreno

Brigitte Dreno has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bandage containing foetal fibroblasts and keratinocytes
    Patent number: 11351201
    Abstract: The present invention describes a composition comprising a mixture of human foetal keratinocyte cells and human foetal fibroblast cells, the ratio between said keratinocyte and fibroblast cells ranging from 0.75 to 2.5, preferably being 1:1 or 7:3. This composition is advantageously included in a bandage, said bandage preferably being sterile and packaged in a container impermeable to microorganisms. The present invention finally concerns the use of this composition as a drug, in particular for treating a skin defect (wound, burn or ulcer).
    Type: Grant
    Filed: December 12, 2013
    Date of Patent: June 7, 2022
    Assignees: Universite De Nantes, Chu Nantes
    Inventors: Brigitte Dreno, Thomas Zuliani, Soraya Saiagh
  • ATROPHIC ACNE SCAR RISK ASSESSMENT TOOL
    Publication number: 20180206778
    Abstract: A method is described for detecting and treating an individual subject having an increased risk for acne scarring.
    Type: Application
    Filed: January 19, 2018
    Publication date: July 26, 2018
    Inventors: Jerry TAN, Brigitte DRENO, Harald GOLLNICK, Sewon KANG, Alison LAYTON, James LEYDEN, Diane THIBOUTOT, Vicente Torres LOZADA, Jonathan GUILLEMOT
  • Bandage Containing Foetal Fibroblasts and Keratinocytes
    Publication number: 20150320804
    Abstract: The present invention describes a composition comprising a mixture of human foetal keratinocyte cells and human foetal fibroblast cells, the ratio between said keratinocyte and fibroblast cells ranging from 0.75 to 2.5, preferably being 1:1 or 7:3. This composition is advantageously included in a bandage, said bandage preferably being sterile and packaged in a container impermeable to microorganisms. The present invention finally concerns the use of this composition as a drug, in particular for treating a skin defect (wound, burn or ulcer).
    Type: Application
    Filed: December 12, 2013
    Publication date: November 12, 2015
    Applicants: CHU NANTES, UNIVERSITE DE NANTES
    Inventors: Brigitte Dreno, Thomas Zuliani, Soraya Saiagh
  • ADMINISTRATION OF ADAPALENE FOR MODULATING THE EXPRESSION OF CD1d OR IL-10
    Publication number: 20100130613
    Abstract: Adapalene or pharmaceutically acceptable salt thereof is administered to an individual in need of such treatment for modulating the expression of CD1d or IL-10 in an inflammatory acneic lesion.
    Type: Application
    Filed: May 19, 2009
    Publication date: May 27, 2010
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventor: Brigitte DRENO
  • ADMINISTRATION OF ADAPALENE FOR MODULATING THE EXPRESSION OF IL-1ra
    Publication number: 20100130614
    Abstract: Adapalene or pharmaceutically acceptable salt thereof is administered to an individual in need of such treatment for modulating the expression of IL-1ra by the cells of acneic epidermis.
    Type: Application
    Filed: May 19, 2009
    Publication date: May 27, 2010
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventor: Brigitte DRENO
  • Novel Use of Zinc Gluconate for Treating Hydradenitis Suppurativa
    Publication number: 20090215889
    Abstract: The invention relates to a novel therapeutic use of zinc gluconate. The zinc gluconate is used in a form for oral administration, at a daily dosage of between 45 and 125 mg, for treating suppurative hidradenitis, or Verneuil's disease.
    Type: Application
    Filed: April 6, 2006
    Publication date: August 27, 2009
    Applicant: LABCATAL
    Inventors: Catherine Suck, Brigitte Dreno, Jacques Bodin